Yazar
committee on ranking fda product categories based on health consequences
2 cilt bulundu.
Cilt sonuçları
A risk-characterization framework for decision-making at the Food and Drug Administration
National Academies (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II · National Academies Press
192 sayfa · 2011
Risk assessment / Product safety / United States / Case studies / Decision making
Risk-Characterization Framework for Decision-Making at the Food and Drug Administration
Institute of Medicine, National Research Council, Division on Earth and Life Studies, Board on Environmental Studies and Toxicology, Phase II Committee on Ranking FDA Product Categories Based on Health Consequences · National Academies Press
Sayfa sayısı yok · 2011
Public health, united states